Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

437
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
437

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nutritional Risk Screening in Gynaecologic Oncology Surgery: Importance, Scoring Systems, Recommendations and Practical Applications.

Journal of clinical medicineĀ·2026
Same author

Automated extraction of ESGO operative report fields from free-text surgical notes using large language models in advanced ovarian cancer.

International journal of gynecological cancer : official journal of the International Gynecological Cancer SocietyĀ·2026
Same author

Prognostic and immunological significance of tryptophan metabolic enzymes across endometrial cancer molecular subtypes.

Gynecologic oncologyĀ·2025
Same author

Mapping the Advanced-Stage Epithelial Ovarian Cancer Landscape Goes Beyond Words: Two Large Language Models, Eight Tasks, One Journey.

Journal of clinical medicineĀ·2025
Same author

Incidence and Predictors of Acute Kidney Injury Following Advanced Ovarian Cancer Cytoreduction at a Tertiary UK Centre: An Exploratory Analysis and Insights from Explainable Artificial Intelligence.

Current oncology (Toronto, Ont.)Ā·2025
Same author

Survival Dynamics in Advanced Ovarian Cancer: R2 Resection Versus No-Surgery Paths Explored.

Cancer control : journal of the Moffitt Cancer CenterĀ·2024

Related Experiment Video

Updated: Sep 3, 2025

Heterotypic Three-dimensional In Vitro Modeling of Stromal-Epithelial Interactions During Ovarian Cancer Initiation and Progression
12:42

Heterotypic Three-dimensional In Vitro Modeling of Stromal-Epithelial Interactions During Ovarian Cancer Initiation and Progression

Published on: August 28, 2012

15.1K

Factors Predicting Surgical Effort Using Explainable Artificial Intelligence in Advanced Stage Epithelial Ovarian

Alexandros Laios1, Evangelos Kalampokis2, Racheal Johnson1

  • 1Department of Gynaecologic Oncology, St James's University Hospital, Leeds LS9 7TF, UK.

Cancers
|July 27, 2022
PubMed
Summary

eXplainable Artificial Intelligence (XAI) can predict surgical effort in epithelial ovarian cancer (EOC) cytoreduction. Human factors and surgical heuristics significantly influence outcomes, guiding better decision-making for improved patient results.

Keywords:
Explainable Artificial Intelligencecomplete cytoreductionepithelial ovarian cancerhuman factorssurgical complexity score

More Related Videos

An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses
10:35

An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses

Published on: November 28, 2010

18.4K
Transplantation Into the Mouse Ovarian Fat Pad
09:25

Transplantation Into the Mouse Ovarian Fat Pad

Published on: September 7, 2016

11.5K

Related Experiment Videos

Last Updated: Sep 3, 2025

Heterotypic Three-dimensional In Vitro Modeling of Stromal-Epithelial Interactions During Ovarian Cancer Initiation and Progression
12:42

Heterotypic Three-dimensional In Vitro Modeling of Stromal-Epithelial Interactions During Ovarian Cancer Initiation and Progression

Published on: August 28, 2012

15.1K
An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses
10:35

An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses

Published on: November 28, 2010

18.4K
Transplantation Into the Mouse Ovarian Fat Pad
09:25

Transplantation Into the Mouse Ovarian Fat Pad

Published on: September 7, 2016

11.5K

Area of Science:

  • Oncology
  • Surgical Oncology
  • Artificial Intelligence in Medicine

Background:

  • Epithelial ovarian cancer (EOC) cytoreductive surgery demands high precision and complex intra-operative decision-making.
  • Human factors significantly influence surgical effort and outcomes in cytoreductive procedures.
  • eXplainable Artificial Intelligence (XAI) offers a potential method to interpret these human factors.

Purpose of the Study:

  • To develop and evaluate predictive models for surgical effort in EOC cytoreduction using machine learning.
  • To identify key patient- and operation-specific features, including human factors, influencing surgical outcomes.
  • To leverage XAI for understanding the impact of intra-operative decision-making on cytoreductive success.

Main Methods:

  • A retrospective cohort study of 560 EOC patients undergoing cytoreductive surgery.
  • Development of predictive models using eXtreme Gradient Boosting (XGBoost) and Deep Neural Network (DNN) algorithms.
  • Application of the SHapley Additive exPlanations (SHAP) framework for model interpretability.

Main Results:

  • A surgical complexity score (SCS) cut-off of five predicted a higher likelihood of incomplete cytoreduction (AUC = 0.644).
  • XGBoost demonstrated superior predictive performance compared to DNN (AUC = 0.77 vs. 0.739).
  • Key factors influencing surgical effort included surgeon experience, patient age, ascites, and intraoperative scores (IMOC, PCI).

Conclusions:

  • XAI can elucidate how human factors inform intra-operative decisions in EOC cytoreduction.
  • Integrating XAI enhances the understanding and application of AI in surgical contexts.
  • XAI facilitates maximizing desired trade-offs in surgical effort for improved outcomes.